Cargando…

Role of lysosomes in physiological activities, diseases, and therapy

Long known as digestive organelles, lysosomes have now emerged as multifaceted centers responsible for degradation, nutrient sensing, and immunity. Growing evidence also implicates role of lysosome-related mechanisms in pathologic process. In this review, we discuss physiological function of lysosom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ziqi, Yue, Pengfei, Lu, Tianqi, Wang, Yang, Wei, Yuquan, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120021/ https://www.ncbi.nlm.nih.gov/pubmed/33990205 http://dx.doi.org/10.1186/s13045-021-01087-1

Ejemplares similares

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

Involvement of inflammasomes in tumor microenvironment and tumor therapies
por: Zhang, Ziqi, et al.
Publicado: (2023)

mRNA vaccine: a potential therapeutic strategy
por: Wang, Yang, et al.
Publicado: (2021)

Role of tumor gene mutations in treatment response to immune checkpoint blockades
por: Wang, Manni, et al.
Publicado: (2019)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
por: Xu, Maosen, et al.
Publicado: (2021)

Targeting TGF-β signal transduction for fibrosis and cancer therapy
por: Peng, Dandan, et al.
Publicado: (2022)

JMJD3 in the regulation of human diseases
por: Zhang, Xiangxian, et al.
Publicado: (2019)

Coronavirus in human diseases: Mechanisms and advances in clinical treatment
por: Lin, Panpan, et al.
Publicado: (2020)

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis
por: Li, Lu, et al.
Publicado: (2020)

CCL5/CCR5 axis in human diseases and related treatments
por: Zeng, Zhen, et al.
Publicado: (2021)

Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials
por: Yuan, Xia, et al.
Publicado: (2019)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
por: Zhu, Chenjing, et al.
Publicado: (2019)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
por: Wei, Xiawei, et al.
Publicado: (2019)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

Jumonji domain‐containing protein 6 protein and its role in cancer
por: Yang, Jing, et al.
Publicado: (2020)

Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases
por: Fu, Minyang, et al.
Publicado: (2022)

Mitochondrial DNA in the regulation of innate immune responses
por: Fang, Chunju, et al.
Publicado: (2015)

Epigenetic regulation of macrophages: from homeostasis maintenance to host defense
por: Chen, Siyuan, et al.
Publicado: (2019)

Molecular mechanisms and clinical management of cancer bone metastasis
por: Wang, Manni, et al.
Publicado: (2020)

Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development
por: Hong, Qiaonan, et al.
Publicado: (2023)

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
por: Hong, Weiqi, et al.
Publicado: (2020)

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
por: Liu, Guihong, et al.
Publicado: (2021)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

Carbon black nanoparticles induce cell necrosis through lysosomal membrane permeabilization and cause subsequent inflammatory response
por: Yuan, Xia, et al.
Publicado: (2020)

Rethinking of Alzheimer's disease: Lysosomal overloading and dietary therapy
por: Yuan, Shu, et al.
Publicado: (2023)

Targeting PI3K in cancer: mechanisms and advances in clinical trials
por: Yang, Jing, et al.
Publicado: (2019)

Lysosomes, Autophagy, and Hormesis in Cell Physiology, Pathology, and Age-Related Disease
por: Moore, Michael N.
Publicado: (2020)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

The Emerging Role of the Lysosome in Parkinson’s Disease
por: Navarro-Romero, Alba, et al.
Publicado: (2020)

JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis
por: Chen, Siyuan, et al.
Publicado: (2023)

Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

The role of lysosomes in cancer development and progression
por: Tang, Tao, et al.
Publicado: (2020)

Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway
por: Liu, Yu, et al.
Publicado: (2022)

DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
por: Wang, Manni, et al.
Publicado: (2021)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway
por: Lu, Tianqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a62e1k8uaa1d7ofbsm3e4suhie